Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Wedbush Raises Price Target on Insulet (PODD) to $48 Following 2Q Beat
August 4, 2016 10:01 AM EDTWedbush reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $48.00 (from $44.00), following the company's 2Q earnings report. Revenues of $87 million were $4 million ahead of consensus. EPS of ($0.07) was 10c better than consensus.
Analyst Tao Levy commented,... More
Leerink Partners Raises Price Target on Insulet (PODD) to $50; Reiterates Outperform
August 4, 2016 7:24 AM EDTLeerink Partners reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $50.00 (from $40.00), following the company's 2Q earnings report.
Analyst Danielle Antalffy commented, "Another strong quarter of outperformance supports our recent view that PODD is... More
Insulet Corporation (PODD) PT Raised to $46 at Piper Jaffray
August 4, 2016 6:52 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on Insulet Corporation (NASDAQ: PODD) to $46.00 (from $41.00) following strong Q2 results.
West commented, "Insulet posted 2Q16 revenues of $87.3M (+44% proforma), 5%+ above the consensus estimate of $83.0M, primarily on strength in... More

